Case Report: Individualized Pulsed Electromagnetic Field Therapy (PEMF) In A Long Covid Patient Using The Adaptive Force As Biomarker
Long COVID poses challenges due to persistent symptoms post-COVID-19 infection. Standard treatments often fall short; however, exploration of new approaches is still going. A recent case study investigates individualized pulsed electromagnetic field (PEMF) therapy as a potential solution. A 24-year-old woman suffered from severe long COVID symptoms for 8 months despite conventional treatments like exercise and supplements. Her symptoms included fatigue, muscle weakness, and brain fog. After ruling out other causes, an Adaptive Force (AF) measurement tool revealed neuromuscular dysfunction. Individualized PEMF therapy targeted the stellate ganglion (C7/T1) of the autonomic nervous system using a frequency of 550 Hz. This is adjusted & based on real-time AF responses, and lasts 15 minutes. The patient showed immediate and sustained improvement in symptoms; furthermore, increased AF values indicated better neuromuscular function. PEMF therapy also helped mitigate a temporary rela